Newsletter

456160 - G2GBIO, Inc.

456160 Summary
Biopharma
Stock Price & Overview
₩37,950 +2,050 (+5.71%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩37,950  ≈ US$27  ·  Market cap ₩0.6tn (≈ $451m)
Home › 456160 › Filings

Investor Relations Event

DART
G2GBIO, Inc.
Filed Jul 1, 2026 KST · IR · receipt 20260701900692

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 기업설명회(IR)개최

456160

Price
₩37,950
Change
+5.71%
Market cap
₩0.6tn
Prev. close
₩35,900
456160 SummaryCompare to Peers

More 456160 filings

Material matter affecting investment judgment (clinical trial result)

08/27/26

5% Ownership Report — Large Holdings

08/21/26

Half-Year Report

08/14/26

Insider / Major Shareholder Holdings Report

08/05/26

Insider / Major Shareholder Holdings Report

06/05/26

5% Ownership Report — Large Holdings ×4

06/05/26